pLKO-Tet-On-shRab27a Citations (3)
Originally described in: Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth.Yang Y, Li CW, Chan LC, Wei Y, Hsu JM, Xia W, Cha JH, Hou J, Hsu JL, Sun L, Hung MC Cell Res. 2018 Aug;28(8):862-864. doi: 10.1038/s41422-018-0060-4. Epub 2018 Jun 29. PubMed Journal
Articles Citing pLKO-Tet-On-shRab27a
| Articles |
|---|
| A mitochondrial NADPH-cholesterol axis regulates extracellular vesicle biogenesis to support hematopoietic stem cell fate. Bonora M, Morganti C, van Gastel N, Ito K, Calura E, Zanolla I, Ferroni L, Zhang Y, Jung Y, Sales G, Martini P, Nakamura T, Lasorsa FM, Finkel T, Lin CP, Zavan B, Pinton P, Georgakoudi I, Romualdi C, Scadden DT, Ito K. Cell Stem Cell. 2024 Mar 7;31(3):359-377.e10. doi: 10.1016/j.stem.2024.02.004. PubMed |
| Muscle-derived miR-126 regulates TDP-43 axonal local synthesis and NMJ integrity in ALS models. Ionescu A, Ankol L, Ganapathy Subramaniam A, Altman T, Magen I, Cohen Y, Danino Y, Gradus-Pery T, Niv Y, Bar Avi O, Geller D, Ibraheem A, Cheng R, Steinberg N, Alfahel L, Duc P, Ergul-Ulger Z, Arslan D, Tan E, Rage F, Riva N, Quattrini A, Bekircan-Kurt CE, Israelson A, Dori A, Hornstein E, Perlson E. Nat Neurosci. 2025 Nov;28(11):2201-2216. doi: 10.1038/s41593-025-02062-6. Epub 2025 Oct 3. PubMed |
| Challenges and caveats in manipulating extracellular vesicle secretion from pancreatic cancer cells. Finan JM, Brody JR. Cancer Biol Ther. 2025 Dec 31;26(1):2569946. doi: 10.1080/15384047.2025.2569946. Epub 2025 Oct 25. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.